Literature DB >> 20117945

Novel insights in FGFR1 regulation: lessons from Kallmann syndrome.

Youli Hu1, Pierre-Marc Bouloux.   

Abstract

Disrupted fibroblast growth factor receptor (FGFR)1 signalling has been shown to cause Kallmann syndrome (KS), a human genetic disorder characterised by olfactory bulb dysgenesis and hypogonadotrophic hypogonadism. Loss-of-function mutations in the KS gene KAL-2/FGFR1 account for roughly 10% of KS cases, leading to the autosomal dominant form of the disease. Anosmin-1, the KAL-1 gene product underlying X-linked KS, modulates FGFR1 signalling via regulation of FGF2/FGFR1/heparin signalling complex assembly and activity. This review covers recent advances in the potential interactions of KS-associated molecules within the FGFR1 signalling complex, and demonstrates a novel mechanism of pre-signalling modulation that mechanistically links an autosomal dominant and sex-linked mode of inheritance of this disease, highlighting the central role of FGFR1 signalling in KS. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117945     DOI: 10.1016/j.tem.2010.01.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  10 in total

Review 1.  New understandings of the genetic basis of isolated idiopathic central hypogonadism.

Authors:  Marco Bonomi; Domenico Vladimiro Libri; Fabiana Guizzardi; Elena Guarducci; Elisabetta Maiolo; Elisa Pignatti; Roberta Asci; Luca Persani
Journal:  Asian J Androl       Date:  2011-12-05       Impact factor: 3.285

2.  Molecular basis for the Kallmann syndrome-linked fibroblast growth factor receptor mutation.

Authors:  Ryan D Thurman; Karuppanan Muthusamy Kathir; Dakshinamurthy Rajalingam; Thallapuranam K Suresh Kumar
Journal:  Biochem Biophys Res Commun       Date:  2012-07-27       Impact factor: 3.575

Review 3.  Genetics of Male Infertility.

Authors:  Filipe Tenorio Lira Neto; Phil Vu Bach; Bobby Baback Najari; Philip Shihua Li; Marc Goldstein
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

Review 4.  Insights into the Regulation on Proliferation and Differentiation of Stem Leydig Cells.

Authors:  Zhuo-Jie Liu; Yong-Hui Liu; Sheng-Yu Huang; Zhi-Jun Zang
Journal:  Stem Cell Rev Rep       Date:  2021-02-17       Impact factor: 5.739

5.  Invertebrate models of kallmann syndrome: molecular pathogenesis and new disease genes.

Authors:  Elia Di Schiavi; Davide Andrenacci
Journal:  Curr Genomics       Date:  2013-03       Impact factor: 2.236

6.  Identification of genomic features in the classification of loss- and gain-of-function mutation.

Authors:  Seunghwan Jung; Sejoon Lee; Sangwoo Kim; Hojung Nam
Journal:  BMC Med Inform Decis Mak       Date:  2015-05-20       Impact factor: 2.796

7.  Point mutations in KAL1 and the mitochondrial gene MT-tRNA(cys) synergize to produce Kallmann syndrome phenotype.

Authors:  Fei Wang; Guo-Dong Huang; Hui Tian; Ying-Bin Zhong; Hui-Juan Shi; Zheng Li; Xian-Sheng Zhang; Han Wang; Fei Sun
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

8.  Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysis.

Authors:  Xiu-Wu Pan; Hao Zhang; Da Xu; Jia-Xin Chen; Wen-Jin Chen; Si-Shun Gan; Fa-Jun Qu; Chuan-Min Chu; Jian-Wei Cao; Ying-Hui Fan; Xu Song; Jian-Qing Ye; Wang Zhou; Xin-Gang Cui
Journal:  Int J Biol Sci       Date:  2020-10-17       Impact factor: 6.580

9.  Clinical Characteristics and Spermatogenesis in Patients with Congenital Hypogonadotropic Hypogonadism Caused by FGFR1 Mutations.

Authors:  Shuying Li; Yaling Zhao; Min Nie; Wanlu Ma; Xi Wang; Wen Ji; Yufan Yang; Ming Hao; Bingqing Yu; Yinjie Gao; Jiangfeng Mao; Xueyan Wu
Journal:  Int J Endocrinol       Date:  2020-11-28       Impact factor: 3.257

10.  A Sprouty4 Mutation Identified in Kallmann Syndrome Increases the Inhibitory Potency of the Protein towards FGF and Connected Processes.

Authors:  Astrid Stütz; Anna Z M Kamptner; Hedwig Sutterlüty
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.